Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiro Koga

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 18, 2010
[Post-travel care--fever in a returned traveler]Toshihiro Koga
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 8, 2007
[Working despite having diseases: Infectious diseases]Toshihiro Koga
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 19, 2011
[Working despite having diseases: Infectious diseases]Toshihiro Koga
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 25, 2009
[Traveler's vaccine use among Japanese expatriates in developing countries]Atsuo Hamada, Toshihiro Koga, Shinji Fukushima
International Journal of Oncology|November 14, 2002
Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47DHiroko Deguchi, Teruhiko Fujii, Shino Nakagawa, et al.
International Journal of Molecular Medicine|August 8, 2002
Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallateHiroshi Yanaga, Teruhiko Fujii, Toshihiro Koga, et al.
Surgery Today|April 23, 2003
Relationship between microvessel density and thermographic hot areas in breast cancerToshiro Yahara, Toshihiro Koga, Shougo Yoshida, et al.
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|January 14, 2011
[The Report of 83(rd) JSOH Conference and a Proposal of Pandemic Flu Preparedness & Response Plan for Businesses and Employers, "Suggested Strategy for Management of Antiviral Drugs"]Hidetaka Suzuki, Koji Wada, Toshihiro Koga, et al.
Oncology Letters|September 12, 2012
Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur·uracilAkihiko Osaki, Shoshu Mitsuyama, Jun-Ichi Kurebayashi, et al.
Chemotherapy|May 12, 2005
Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II studyReiki Nishimura, Takahiro Ogawa, Masato Kato, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Rinsho Byori. the Japanese Journal of Clinical Pathology|September 18, 2010
[Post-travel care--fever in a returned traveler]Toshihiro Koga
Rinsho Byori. the Japanese Journal of Clinical Pathology|December 8, 2007
[Working despite having diseases: Infectious diseases]Toshihiro Koga
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 19, 2011
[Working despite having diseases: Infectious diseases]Toshihiro Koga
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 25, 2009
[Traveler's vaccine use among Japanese expatriates in developing countries]Atsuo Hamada, Toshihiro Koga, Shinji Fukushima
International Journal of Oncology|November 14, 2002
Analysis of cell growth inhibitory effects of catechin through MAPK in human breast cancer cell line T47DHiroko Deguchi, Teruhiko Fujii, Shino Nakagawa, et al.
International Journal of Molecular Medicine|August 8, 2002
Prevention of carcinogenesis of mouse mammary epithelial cells RIII/MG by epigallocatechin gallateHiroshi Yanaga, Teruhiko Fujii, Toshihiro Koga, et al.
Surgery Today|April 23, 2003
Relationship between microvessel density and thermographic hot areas in breast cancerToshiro Yahara, Toshihiro Koga, Shougo Yoshida, et al.
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|January 14, 2011
[The Report of 83(rd) JSOH Conference and a Proposal of Pandemic Flu Preparedness & Response Plan for Businesses and Employers, "Suggested Strategy for Management of Antiviral Drugs"]Hidetaka Suzuki, Koji Wada, Toshihiro Koga, et al.
Oncology Letters|September 12, 2012
Dose-escalation phase I study in metastatic breast cancer patients with combination of paclitaxel and tegafur·uracilAkihiko Osaki, Shoshu Mitsuyama, Jun-Ichi Kurebayashi, et al.
Chemotherapy|May 12, 2005
Weekly paclitaxel in the treatment of advanced or metastatic breast cancer previously treated or not treated with docetaxel: a phase II studyReiki Nishimura, Takahiro Ogawa, Masato Kato, et al.
Pageof 2